1. CD47: a potential immunotherapy target for eliminating cancer cells

   • F. Kong
   • F. Gao
   • Y. Jia

   Review Article 01 February 2016 Pages: 1051 - 1055

   

2. Regulation of epithelial–mesenchymal transition in endometrial cancer: connecting PI3K, estrogen signaling, and microRNAs

   • C. N. Kent
   • I. K. Guttilla Reed

   Review Article 08 February 2016 Pages: 1056 - 1061

   

3. Survival in glioblastoma: a review on the impact of treatment modalities

   • P. D. Delgado-López
   • E. M. Corrales-García

   Review Article 10 March 2016 Pages: 1062 - 1071

4. Is regorafenib providing clinically meaningful benefits to pretreated patients with metastatic colorectal cancer?

   • P. García-Alfonso
   • J. Feliú
   • J. García-Foncillas

   Review Article 01 April 2016 Pages: 1072 - 1081

5. Serum uric acid as a surrogate marker of favorable response to bevacizumab treatment in patients with metastatic colon cancer

   • F. Selcukbiricik
   • M. Kanbay
   • N. M. Mandel

   Research Article 19 January 2016 Pages: 1082 - 1087

   

6. Consensus and controversies in the definition, assessment, treatment and monitoring of BTcP: results of a Delphi study

   • J. Boceta
   • A. De la Torre
   • R. Sánchez-de la Rosa

   Research Article Open access 08 February 2016 Pages: 1088 - 1097

   

7. The appropriate axillary procedure after a positive sentinel node in breast cancer patients: the “Hôpital Tenon” score revisited. A two-institution study

   • I. Barco
   • A. García-Fernández
   • M. García-Font

   Research Article 26 February 2016 Pages: 1098 - 1105

   

8. Preoperative low-dose weekly cisplatin and continuous infusion fluorouracil plus hyperfractionated radiotherapy in stage II–III esophageal carcinoma

   • M. Caro
   • A. Font
   • J. Fernández-Llamazares

   Research Article 08 February 2016 Pages: 1106 - 1113

   

9. Epidemiological characteristics of a Spanish cohort of patients diagnosed with squamous cell carcinoma of head and neck: distribution of risk factors by tumor location

   • R. Seijas-Tamayo
   • J. Fernández-Mateos
   • J. J. Cruz-Hernández

   Research Article 25 April 2016 Pages: 1114 - 1122

10. Valproic acid inhibits the angiogenic potential of cervical cancer cells via HIF-1α/VEGF signals

    • Y. Zhao
    • W. You
    • R. Du

    Research Article 04 March 2016 Pages: 1123 - 1130

    

11. Extreme liver surgery as treatment of liver tumors involving the hepatocaval confluence

    • C. Codony
    • S. López-Ben
    • J. Figueras

    Research Article 10 March 2016 Pages: 1131 - 1139

    

12. Residual neck disease management in squamous-cell carcinoma of the head and neck treated with radiotherapy plus cetuximab

    • R. Montal
    • M. Oliva
    • R. Mesia

    Research Article 10 March 2016 Pages: 1140 - 1146

    

13. Safety of vemurafenib in patients with BRAF ^V600 mutated metastatic melanoma: the Spanish experience

    • A. M. Arance
    • A. Berrocal
    • E. Espinosa

    Research Article 17 March 2016 Pages: 1147 - 1157

    

14. Stereotactic body radiotherapy in non-operable lung cancer patients

    • R. E. Vadalà
    • A. Santacaterina
    • S. Pergolizzi

    Correspondence 29 September 2016 Pages: 1158 - 1159